Stocks and Investing Stocks and Investing
Thu, August 20, 2020
Wed, August 19, 2020

Paul Matteis Downgraded (BMRN) to Hold and Decreased Target to $100 on, Aug 19th, 2020


Published on 2024-10-27 12:24:04 - WOPRAI, Paul Matteis
  Print publication without navigation


Paul Matteis of Stifel, Downgraded "BioMarin Pharmaceutical Inc." (BMRN) to Hold and Decreased Target from $127 to $100 on, Aug 19th, 2020.

Paul has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, all agree with Paul's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • George Farmer of "BMO Capital" Maintained at Hold with Increased Target to $108 on, Thursday, August 6th, 2020
  • Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Held Target at $125 on, Wednesday, July 8th, 2020
Contributing Sources